Arikayce Nets $21M in Q1 Treating MAC Lung Disease | RT
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology - ScienceDirect
Taking ARIKAYCE® | ARIKAYCE® (amikacin liposome inhalation suspension)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARIKAYCE safely and effe
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Arikayce: Package Insert - Drugs.com
PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)
ARIKAYCE Instructions For Use
Arikayce: Package Insert - Drugs.com
ARIKAYCE Dosage & Rx Info | Uses, Side Effects
Arikayce: Side effects, dosages, alternatives, and more
ARIKAYCE® (amikacin liposome inhalation suspension) - Insmed
Other Review(s)
Resources for HCPs | ARIKAYCE® (amikacin liposome inhalation suspension)
Arikayce Approved to Treat Mycobacterium Avium Complex Lung Disease - MPR
Pari Pharma lands FDA nod for Lamira nebulizer - Drug Delivery Business
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
What is Arikayce: Uses, Warnings, Interactions & FAQs
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARIKAYCE safely and effe
Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections | Business Wire
Insmed Stock (INSM): Checking A Top Outperformer | Seeking Alpha
Assessment report
